NSN 6505-01-656-4228 of Fentanyl Transdermal System - Product Details
Just NSN Parts, owned and operated by ASAP Semiconductor, is an industry-leading distributor of NSN 6505-01-656-4228 parts applicable in the aviation and defense industries. We aim to simplify the NSN 6505-01-656-4228 parts procurement process by enabling our customers to search through our inventory quickly and efficiently. Type in your desired NSN 6505-01-656-4228 part number such as NDC00378-9119-98, NDC00406-9012-76, NDC00781-7240-55, NDC50458-0090-05 into our search engine and, in a matter of seconds, available stock will appear.
We pride ourselves on our attention to detail and focus on quality control. We are FAA AC 0056B accredited and AS9120B, ISO 9001:2015 certified. We offer our customers a personalized and reliable service that will change your parts procurement process. If you would like to receive a quote today, fill out a request for quote form today.
| Alternative NSN: 6505-01-656-4228 |
| Item Name:Fentanyl Transdermal System |
| NIIN: 016564228 |
| NCB Code: USA (01) |
| Manufacturers: Mylan Pharmaceuticals Inc , Mallinc Krodt Inc , Sandoz Inc , Janssen Pharmaceuticals Inc |
Manufacturer's List for NSN 6505-01-656-4228, 6505016564228
Part Number Related To NSN 6505-01-656-4228, 6505016564228
| Part No | NSN | Item Name | QTY | RFQ |
|---|---|---|---|---|
| NDC00378-9119-98 | 6505-01-656-4228 | fentanyl transdermal system | Avl | RFQ |
| NDC00406-9012-76 | 6505-01-656-4228 | fentanyl transdermal system | Avl | RFQ |
| NDC00781-7240-55 | 6505-01-656-4228 | fentanyl transdermal system | Avl | RFQ |
| NDC50458-0090-05 | 6505-01-656-4228 | fentanyl transdermal system | Avl | RFQ |
Characteristics Data of NSN 6505016564228
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 12 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (12 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH; STORE UP TO 20 C TO 25 C (68 F TO 77 F); STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
| CSLZ | Usual Dose | 12 MCG/HR |
| CBBL | Features Provided | INDIVIDUALLY SEALED |
| CRYC | Controlled Substance Classification | SCHEDULE II |
| CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-12 (FENTANYL TRANSDERMAL SYSTEM) 12MCG/HR, 5S |
| MRC | Decoded Requirement | Clear Text Reply |
Get More Relevant NSN for NSN 6505-01-656-4228, 6505016564228
